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Recent large trials in North America and Europe
have defined the important role of carotid endar-
terectomy (CEA) in the treatment of symptomatic
and asymptomatic carotid artery disease.1-4 The
studies have shown that the degree of carotid steno-
sis is a critical factor in decision making about the
benefit of CEA.
On the basis of these and other studies, one
might reasonably speculate that serial duplex scan
surveillance of the carotid artery is an important tool,
especially in patients who are asymptomatic and
whose degree of stenosis does not initially warrant
CEA. However, the natural history of the progres-
sion of carotid stenosis is not well defined, despite
multiple studies that have directly or indirectly
addressed the topic.5-13 In fact, these studies have
yielded conflicting conclusions about the value of
serial duplex scan surveillance in patients who are
asymptomatic, which range from a report that serial
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duplex scan follow-up has minimal predictive power5
to a recommendation for the aggressive application
of serial surveillance.8
We undertook in this study to delineate the nat-
ural history of the progression of carotid stenosis as
measured by means of duplex ultrasound scan in a
large number of patients who were asymptomatic at
the Pittsburgh Veterans Administration Medical
Center and to define clinically useful predictors of
progression. We also sought to determine the role
and value of serial duplex scan surveillance in these
patients.
PATIENTS AND METHODS
In the 10-year period from September 1988 to
September 1997, the noninvasive vascular laboratory
at the Pittsburgh Veterans Administration Medical
Center performed 6775 carotid artery duplex scan
studies in 4171 patients. We identified 1004 patients
with the following characteristics: (1) asymptomatic
at the time of the initial study, (2) at least one follow-
up study more than 6 months after the baseline
study, and (3) at least one carotid artery that had not
undergone CEA. Asymptomatic was defined as the
absence of transient ischemic attack, amaurosis fugax,
or stroke in the 6-month interval before the baseline
study. The initial patient referral to the laboratory
was done by internists and surgeons for a large vari-
ety of indications. Although some of the follow-up
studies were ordered by the patients’ physicians,
most were performed because the laboratory sched-
ules routine follow-up appointments for all patients
at intervals of 6 to 12 months. This is the result of a
prospective strategy to track the clinical and ultra-
sound scan course of these patients.
The data on the carotid arteries that had under-
gone CEA before the baseline study were excluded
from analysis. In addition, if a patient underwent
CEA after the baseline study, then the stenosis data
after the CEA were excluded from analysis. From
the early 1990s, we had a policy of offering CEA to
patients at good risk with severe ( ‡ 80%) stenosis.
However, several asymptomatic severe lesions were
followed among the patients who declined surgery
or among those with significant medical risk factors.
At each visit to the vascular laboratory, a regis-
tered nurse obtained a detailed neurologic history
and “yes/no” responses to questions about smoking,
hypertension, hyperlipidemia, diabetes, angina, and
myocardial infarction. The blood pressures in both
arms were obtained, and a carotid artery duplex scan
study (Accuson 128XP, Mountain View, Calif) was
performed. The degree of internal carotid artery
(ICA) stenosis was determined on the basis of veloc-
ity criteria that were validated at our institution by
means of comparison with contrast angiography
(Table I). With angiography as a gold standard, the
sensitivity and specificity ranged from 70% to 99%.
We found an excellent overall agreement between
duplex scanning and angiography ( k = 0.85). The
reproducibility of the duplex scan data was also excel-
lent, as inferred from a 92% incidence rate of finding
the same degree of stenosis among 48 studies that
were repeated at intervals of less than 1 month. The
ratio of external carotid artery (ECA) peak systolic
velocity (PSV) to common carotid artery PSV was
also recorded at each visit. The ECA/common
carotid artery PSV ratio of 2.0 or more was used to
determine ECA stenosis ‡ 50%.
We defined progression as an increase in ICA
stenosis to ‡ 50% for carotid arteries with baseline
stenosis <50% or as an increase to a higher category
of stenosis if the baseline stenosis was ‡ 50%. Thus, a
transition from the “none” category to the “mild”
category was not considered to be progression, but
all the other increases in stenosis category were con-
sidered to be progression.
The data initially were recorded in separate com-
Table I. Velocity criteria and validation statistics
ICA/CCA PSV Inferred degree of stenosis Sensitivity (%) Specificity (%) Kappa statistic (95% CI)
0.1 to 1.4 None 95.6 99.2
1.5 to 1.9 Mild (15% to 49%) 69.6 95.1
2.0 to 3.9 Moderate (50% to 79%) 80.5 78.7 0.85
‡ 4.0, with ICA PSV <125 cm/s Severe (80% to 99%) 95.3 82.8 (0.82 to 0.89)
‡ 4.0, with ICA PSV >125 cm/s Preocclusive 85.1 87
0 (no flow in ICA) Occluded 90.9 89.3
ICA, Internal carotid artery; CCA, common carotid artery; PSV, peak systolic velocity; CI, confidence interval.
Sensitivity, specificity, and kappa statistic were determined after review of 487 internal carotid arteries visualized in 248 consecutive
carotid artery angiograms obtained in a 4-year period (October 1993 to June 1997). The angiographic data were compared with the
respective duplex scan study results. For calculation of the kappa statistic, we used a customized computer program.14
Table II. Demographic and clinical features
Baseline patient characteristics (n = 1004 patients)
Age (years) 65.5
Sex (% male) 98%
History of:
Angina 33%
Myocardial infarction 35%
Current smoking 42%
Any smoking 90%
Hyperlipidemia 41%
Diabetes 31%
Hypertension 56%
Baseline distribution of ICA stenosis (n = 1701 ICAs)
None 57%
Mild (15% to 49%) 18%
Moderate (50% to 79%) 14%
Severe (80% to 99%) 8%
Preocclusive 2%
Occluded 0%*
ICA, Internal carotid artery.
*Occluded internal carotid arteries were excluded from analysis
(see Methods section).
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puter files for each study with software from Life
Sciences (Greenwich, Conn). These data then were
extracted with a customized program written by one
of the authors in QuickBasic (Microsoft, Redmond,
Wash) and then transferred to Access (Microsoft), a
relational database. In our analyses, we used Access
for descriptive statistics, SAS (SAS Institute, Cary,
NC) for the Cox proportional hazards model and the
Kaplan-Meier method plots, and Excel (Microsoft)
for the exponential curve fitting of the Kaplan-Meier
method plots. Progression was considered to be a
censoring event for the involved carotid artery, in the
same way that death is treated in a mortality rate
study. A carotid artery was considered to be with-
drawn if the CEA was performed after the baseline
study and at the point of the last serial duplex scan
study. The Kaplan-Meier method plots were carried
out to the time point when the standard error reached
10% of the value of the survival distribution function.
Statistical significance was inferred at the .05 level.
RESULTS
The results are derived from the analysis of 1701
carotid arteries in 1004 patients. Table II shows the
baseline demographic and clinical characteristics of the
patients. The vast majority of the patients were men, as
expected in a Veterans Administration hospital setting.
The clinical risk factors for atherosclerosis were typical
for patients followed in major vascular laboratories.
Table II also shows the baseline distribution of ICA
stenosis among the 1701 carotid arteries. The mean
follow-up period of the patients was 28 months, and
the mean number of scans per patient was 2.9.
The incidence rate of progression and the mean
time to progression are shown in Table III for each
category of baseline stenosis. The time-dependent
risk of progression also was analyzed with the
Kaplan-Meier method and the Cox proportional haz-
ards model. The risk of progression among all the
ICAs was found to increase steadily from the point of
entry for as long as 7 years of follow-up. This is
shown by the persistent negative slope of the solid
line in Fig 1. These data closely follow an exponen-
tial curve (correlation coefficient, 0.99). The curve
fitting shows an annualized progression rate of 9.3%
of the at-risk population.
We first used the univariate proportional hazards
model to analyze the predictive value of 18 variables
available at the baseline study (Table IV). Of these
variables, we found that seven had statistically signifi-
cant effects on the time to progression. The seven vari-
ables were entered into a stepwise multivariate model,
and four were found to retain an independent predic-
tive value for the time to progression. These variables
are indicated with boldface in Table IV. The Kaplan-
Meier method curves for stratification with the two
most important variables (baseline ipsilateral ICA
stenosis ‡ 50% and baseline ipsilateral ECA stenosis
‡ 50%) are shown in Fig 1. Stratification with the other
variables is not shown to maintain clarity of the figure.
The annualized risk of progression for the
patient group that had none of the four risk factors
was found to be 3.2% of the at-risk population, as
determined from exponential curve fitting (correla-
tion coefficient, 0.95). With this as a baseline risk,
Table V shows the projected progression risks for all
the possible combinations of the four variables iden-
tified in the multivariate model.
The incidence rates of the progression of carotid
stenosis observed in this study are substantially high-
er than those reported in a recent study by Lewis et
al.5 Table VI shows a direct comparison of the pro-
gression incidence rate as a function of baseline
carotid stenosis.
Of the 1701 carotid arteries that were studied, ipsi-
lateral ischemic neurologic events (stroke, transient
ischemic attack, amaurosis fugax) occurred in associa-
tion with 14.0%. The frequency was significantly high-
er among carotid arteries that exhibited progression
(21.0% vs 11.9%; P < .001). However, the event fre-
quency was only marginally higher among the carotid
arteries with baseline ICA stenosis ‡ 50%, and the dif-
ference was not significant (14.0% vs 13.9%; P = .98).
women. Unfortunately, the Lewis paper did not
report the effect of gender in their analysis.
The Lewis paper also found that the progression
of carotid stenosis was not a predictor of ischemic
neurologic events, but baseline stenosis was a pre-
dictor. Our data show the opposite. This distinction
between the two studies is in part caused by the
higher incidence rate of progression events that we
observed in this study. However, another factor is
the lower proportion of patients with advanced
degrees of baseline stenosis in the current study.
Such a distribution would be expected to reduce the
importance of baseline stenosis and increase the
importance of progression in the prediction of neu-
rologic events.
Our strategy was to identify the variables avail-
able to the clinician at the baseline study that can be
used to predict the risk of progression. After a pre-
liminary univariate analysis, we identified four vari-
ables that had an independent predictive value in a
multivariate model (Table IV).
Our finding that baseline ICA stenosis ‡ 50% is a
strong predictor of progression is consistent with the
data reported by Nehler et al.9 In that analysis, an
ICA PSV of more than 175 cm/s was a useful pre-
dictor of early stenosis progression. Our data also con-
firm the finding of Nehler et al9 that systolic hyper-
tension is a predictor of progression. Interestingly, we
found that the presence of a systolic blood pressure of
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DISCUSSION
This is the largest natural history study to date of
the progression of carotid stenosis. We found that the
risk of stenosis progression is substantial and steadily
increases with time. In each year of follow-up, approx-
imately 9.3% of the at-risk population exhibited pro-
gression. As indicated by the persistent negative slope
of the solid line in Fig 1, this pattern of ongoing pro-
gression persisted to 7 years of follow-up.
Our data are sharply at odds with a recent large
natural history study5 derived from a secondary
analysis of data from the Asymptomatic Cervical
Bruit Study. From their analysis, Lewis et al5 con-
cluded that the predictive power of serial duplex scan
is poor, and they suggested that its use could not be
supported. They observed incidence rates of stenosis
progression that were much lower than were
observed in the current study (Table VI). One possi-
ble reason for this difference is that the patient
cohort in the Lewis study was 60% female, in contrast
with 98% male cohort in the current study of veteran
patients. The male patients had a much higher risk
for progression in our univariate analysis (Table II),
but sex did not retain importance in the multivariate
model. The failure of patient gender to retain predic-
tive importance may be simply a result of the small
number of women in our patient cohort, and it is
possible that gender may play an important role in a
cohort that consists of a significant proportion of
Fig 1. Kaplan-Meier method curves show probability of being free from progression as a func-
tion of time. Solid line incorporates all 1701 carotid arteries in study. Additional four curves
are result of stratification of carotid arteries by two dichotomous variables (baseline ICA steno-
sis, ‡ 50%; baseline ECA stenosis, ‡ 50%).
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more than 160 mm Hg at the time of the baseline
study was a useful predictor but that a history of
hypertension was not in itself a significant predictor
(Table IV). This suggests that inadequately controlled
hypertension is the true risk factor—not the mere
presence of the condition. However, our data do not
allow us to definitively test this hypothesis.
We also identified contralateral ICA stenosis
‡ 50% and ipsilateral ECA stenosis ‡ 50% as significant
risk factors (Table IV) for ICA stenosis progression.
To our knowledge, this is the first report of the inde-
pendent predictive importance of these factors.
The finding that baseline anatomic features (ipsi-
lateral ICA and ECA stenosis, contralateral ICA
stenosis) predict progression is intuitively logical
because it implies that patients who have advanced
atherosclerosis at the baseline are the ones in whom
more stenosis is most likely to develop in the future.
However, the identification of the magnitude of inde-
pendent risk attributable to these factors has signifi-
cant practical value in patient care. Furthermore, the
finding that systolic blood pressure is a significant pre-
dictor raises the possibility that appropriate antihyper-
tensive therapy can reduce the progression rates.
Table III. Progression of stenosis by category of baseline stenosis
Baseline stenosis category N Percent exhibiting progression Mean time to progression (months)
None 967 11.5 38.4
Mild 306 38.2 31
Moderate 246 43.5 20.6
Severe 144 26.6 21.1
Preocclusive 38 31.6 13.5
Occluded 0* N/A N/A
All categories 1701 22.6 28.7
*Occluded internal carotid arteries were excluded from analysis (see Methods section).
Table IV. Results of Cox proportional hazards model
Univariate model Multivariate model
Entered into 
multivariate 
P value Risk ratio* 95% CI model P value Risk ratio* 95% CI
Demographic variables
Age (years)† 0 1.014† 1.00 to 1.03 yes >.1
Sex (male) 0 9.4 1.32 to 67.1 yes >.1
Race (nonwhite) .19 no
Clinical variables
Angina .1 no
Blood pressure, systolic >160 mm Hg 0 1.41 1.14 to 1.76 yes 0 1.37 1.05 to 1.78
Blood pressure, diastolic >90 mm Hg .55 no
Diabetes .1 no
Hyperlipidemia .1 1.23 1.00 to 1.52 yes >.1
Hypertension .12 no
Myocardial infarction .18 no
Obesity .5 no
Smoking status (current smoker) .1 no
Smoking status (never smoked) .25 no
Vertigo episodes .58 no
Duplex scan–related variables
Baseline ICA stenosis ‡ 50% 0 3.23 2.62 to 3.96 yes 0 3.34 2.46 to 4.53
Baseline ECA stenosis ‡ 50% 0 2.51 1.96 to 3.23 yes 0 1.51 1.11 to 2.04
Baseline contralateral ICA ‡ 50% 0 1.87 1.52 to 2.30 yes 0 1.41 1.07 to 1.85
Side (left) .13 no
CI, Confidence interval; ICA, internal carotid artery; ECA, external carotid artery.
*Risk ratio is shown only for variables that have a statistically significant effect on probability of progression.
†All variables are dichotomous (no/yes) except age, which was analyzed as a continuous variable. Therefore, the risk ratio for age is the
increased risk associated with a 1-year increase in age.
Boldfacing indicates variables that retained independent predictive value in the final multivariate model.
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This study does not directly address whether the
early detection of the progression of carotid stenosis
in patients who are asymptomatic leads to clinical
benefits, such as reduction in stroke risk. However,
we did find that the progression of ICA stenosis cor-
relates with ipsilateral ischemic neurologic events but
that baseline stenosis does not. Furthermore, other
studies have shown that stroke reduction can be
achieved with carotid endarterectomy in patients
who are asymptomatic with hemodynamically signif-
icant stenosis.2,4 Therefore, we propose that the early
detection of the progression of carotid stenosis is
clinically important. In this context, the status in any
given patient of the four risk factors identified in this
study can guide decisions about the frequency of ser-
ial duplex scan follow-up. The risks conferred by the
variables are multiplicative, so that a patient who has
all four risk factors would have nearly a 10-fold
increase in risk as compared with a patient who has
none of the risk factors. As shown in Table V, various
combinations of the risk factors yield projected annu-
alized progression risks that range from 3.2% (no risk
factors) to 31.5% (all four risk factors present). We
speculate that it is cost effective to assign patients to
a 2-year follow-up if their annualized progression
rate is 5% or less, to annual screening for the middle
range of 6% to 20%, and to a 6-month follow-up for
the high range of more than 20% annualized pro-
gression rate. However, these recommendations
must be validated with further studies (preferably
prospective) and by detailed cost analyses.
In addition to the risk of progression, another fac-
tor in the decision about the frequency of serial duplex
scan evaluation is the time-dependent probability of an
adverse neurologic event after disease progression has
occurred. Further study and data accumulation will be
needed to address this important issue.
CONCLUSION
In a large serial duplex scan study of veterans
who were asymptomatic and who were followed up
to 7 years after entry in the study, we found a 9.3%
annual rate of progression of carotid stenosis. We
identified four independent risk factors for the pro-
gression in a multivariate model. Three of these
quantify the baseline degree of extracranial carotid
atherosclerosis, and the fourth was systolic blood
pressure of more than 160 mm Hg. The risk of pro-
Table V. Annualized progression risk with all possible risk factor combinations
Contralateral Projected annualized risk
Ipsilateral ICA ‡ 50% Ipsilateral ECA ‡ 50% ICA ‡ 50% SBP > 160 mm Hg of progression (%)
3%
X 4%
X 5%
X X 6%
X 5%
X X 7%
X X 7%
X X X 9%
X 11%
X X 15%
X X 15%
X X X 21%
X X 16%
X X X 22%
X X X 23%
X X X X 32%
ICA, Internal carotid artery; ECA, external carotid artery; SBP, systolic blood pressure; X, indicates the presence of a given risk factor.
Progression risks are rounded to the nearest integer.
Table VI. Incidence rates of progression of
carotid stenosis as a function of baseline stenosis*
Baseline stenosis Lewis et al5 Muluk et al† (current study)
None‡ 3.25% 11.5%
Mild 19.5% 38.2%
Moderate 22.2% 43.5%
Severe§ 9.7% 26.6%
*Definition of progression used in the current paper was applied
to the data in Table II of reference 5.
†Values are derived from Table III.
‡The “0” and “1 to 15” categories in reference 5 were combined
into the “none” category.
§The “severe” and “preocclusive” categories in the current man-
uscript were combined into the “severe” category.
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gression varied by 10-fold depending on the absence
or the presence of all four factors. These data may be
useful in determining the frequency of serial duplex
scan surveillance in different patient groups.
We gratefully acknowledge P. Elaine Householder,
Margaret Brunsell, and Marlene Waszkiewicz (the nurses
who performed the carotid testing in the Veterans
Administration vascular laboratory), and our nurse clinical
coordinator Stacy Love.
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Dr Mark A. Mattos (Springfield, Ill). With the advent of
duplex scanning, an increasing number of patients who are
asymptomatic with varying degrees of carotid artery disease
are being identified. Clearly, as the asymptomatic carotid tri-
als have shown us, not all asymptomatic internal carotid
stenoses act in a similar manner, clinically or anatomically.
Some patients will remain asymptomatic despite having
carotid stenoses that undergo progression to a higher level of
severity, and other patients will have ipsilateral neurologic
symptoms with stenoses that do not progress to a higher
degree of narrowing. Therefore, the key to proper evaluation
and management of these ubiqutious lesions is to accurately
determine their natural history. In doing so, one should be
able to answer the following questions: What lesions will
undergo progression to a higher level of severity? How fre-
quently does it occur? To what severity? Does progression of
disease predict the development of future ipsilateral neuro-
logic events? What patients then should undergo operation,
and who should be monitored with serial duplex scans?
Dr Muluk and associates present a large collection of
data designed to answer the above questions. The authors’
goals were to delineate the natural history of asympto-
matic internal carotid artery stenosis, to identify the vari-
ables that would predict the progression of carotid artery
stenosis, and to determine the role and value of duplex
scan surveillance in these patients. On the basis of their
interpretation of the data, we now know the following:
1. The progression of carotid disease increases over
time, at the rate of approximately 9% per year, and
by the 7th year of follow-up, more than one half of
all patients at risk had had some degree of disease
progression.
2. Certain risk factors are more likely to be associated
with the progression of carotid stenosis. Individual
factors or combinations of these four specific risk
factors predicted a risk of disease progression that
ranged from 3.2% to 32% annually.
3. Carotid arteries that exhibit progression of disease
were associated with ipsilateral ischemic neurolog-
ic events to a much greater extent than arteries
without disease progression (21% vs 12%, respec-
tively).
However, although I applaud Dr Muluk for providing
us with a fine presentation, I believe that many important
questions remain unanswered or unaddressed, and I have
concerns regarding the following issues.
First, Dr Muluk, I question whether or not patient selec-
tion bias has entered into your study. Only 24% of your study
DISCUSSION
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population had a ‡ 50% internal carotid stenosis (presumably
the subset of patients at highest risk for associated ischemic
neurologic events and progression of carotid artery stenosis),
which makes this a natural history study primarily of lesions
with a ≤50% stenosis. During your study period, how many
patients who were asymptomatic with a >50% internal
carotid stenosis underwent prophylactic carotid endarterec-
tomy and thus were excluded from the study population?
Why did some patients undergo surgery although other
patients with similar disease severity did not? Is it possible
that the exclusion of this subset of patients who underwent
carotid endarterectomy (who I assume had carotid artery
stenosis of 50% to 99%) may have altered the natural history
of your patient population, thereby resulting in a decreased
incidence rate of ipsilateral neurologic ischemic events and
disease progression rates? Could the authors comment on
the implications that this would have on their conclusions?
Second, the authors provide an overall risk of disease
progression of 9% per year and a development rate of ipsilat-
eral neurologic symptoms associated with disease progres-
sion of 21% for the entire group of patients. However, I
have concerns that these data may not be relevant or
applicable to patients who are asymptomatic with different
degrees of carotid disease. Therefore, I ask the authors to
comment on the following questions:
1. Did the authors perform an analysis of the inci-
dence rate of disease progression on the basis of the
severity of baseline internal carotid stenosis?
2. Was there a correlation between the severity of
baseline carotid stenosis and the incidence rate of
carotid disease progression? That is, did a higher
degree of internal carotid stenosis predict greater
disease progression?
3. Was there a correlation between the severity of
baseline carotid stenosis and the incidence rate of
ipsilateral neurologic events? That is, did a higher
degree of internal carotid stenosis predict a greater
incidence rate of ipsilateral neurologic events?
4. What subgroup of patients with disease progres-
sion was associated with the highest incidence rate
of ipsilateral neurological symptoms?
Third, the authors indicate that their results justify the
use of serial duplex scanning to follow internal carotid
stenosis. However, they do not provide any subset analysis
of disease progression on the basis of severity of baseline
carotid stenosis. Therefore, I ask the authors whether or not
their results can provide answers to the following questions:
1. Which patients in your study population should
receive serial duplex scan follow-up?
2. How frequently should these scans be performed?
Would you determine your scanning frequency on
the basis of the annual risk of disease progression
or on the mean length of time to disease progres-
sion?
3. Have you performed any calculations regarding the
number of strokes that might be prevented if such
a duplex scan surveillance program is instituted for
this patient population?
Fourth, the authors report that baseline ipsilateral exter-
nal carotid artery stenosis >50% was predictive for progres-
sion of internal carotid stenosis. What validation criteria were
used to determine a ‡ 50% stenosis of the external carotid
artery? Can the authors provide sensitivity and specificity
data regarding the accuracy of their duplex scan criteria for
determining an external carotid artery stensosis >50%?
Dr Satish C. Muluk (Pittsburgh, Pa). I will try to
answer the questions Dr Mattos raised as best I can. The
first question related to the question of a possible selection
bias. Admittedly, and I think this applies to any study of this
sort, there is a certain bias because we are limited to the
patients who are referred to our vascular laboratory. We cer-
tainly did not randomly select among all the veteran patients
for this study.
On the other hand, the fact that most of our patients had
initial degrees of stenosis <50% strengthens the manuscript
in the sense that we are examining a population of patients
who we would indeed consider for serial duplex scan sur-
veillance. Certainly, the patients with more severe degrees of
stenosis are less likely to need serial duplex scan surveillance.
So, we think that actually is a strength of the study.
Certainly, patients did undergo prophylactic carotid
endarterectomy, but our policy has been to do that only at
the point at which severe stenosis has developed in the 80%
to 99% range. Because of that, I do not think that policy
would really affect our analysis of progression. It might affect
the number of neurologic events that we pick up because we
might prevent some of those events with prophylactic
carotid endarterectomy. But, on the other hand, because we
do not offer endarterectomy until the severe stage, it should
not really affect our identification of progression, which I
would point out is really the key focus of this paper.
It is true that these results may not be applicable to all
the patients with carotid stenosis, but only in the sense
that we are limited to the population of patients who were
in the study—namely, the veteran patients. But that is an
issue, of course, that is going to apply to any study, regard-
less of how large.
Dr Mattos also asked whether the incidence rate of
disease progression is related to the severity of baseline
stenosis. And, in fact, it is. One of the principal conclu-
sions was that the increased level of baseline stenosis does
correlate with the disease progression.
Another question was related to whether these results
justified the use of serial duplex scanning. We certainly
think that they do. The annualized risk of progression was
quite high even in the unselected group of patients. And if
various risk factors are present in different combinations,
the risk increases as high as 30% or more per year with pro-
gression. Although we have not performed a detailed
cost/benefit analysis yet, we are in the process of doing
that. We believe that the frequency of progression is high
enough, certainly, to warrant a serial duplex scan surveil-
lance at least in certain subsets of patients.
We tried to avoid making specific recommendations
from these data about the actual length or intervals of fol-
low-up examination because we thought that would be
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overreaching. Instead, we wanted to present the data to
demonstrate that these risk factors do in fact correlate with
the risk of progression.
The final question that Dr Mattos raised about the
issue of statistics is quite valid. I would point out that the
change in the statistics relates only to the calculation of the
number of neurologic events, which was incorrect in the
initial abstract, but that certainly does not affect the main
conclusions of the paper, which all relate to the risk of pro-
gression. That is the main focus of the paper. And the pro-
gramming error that led to that error in statistics does not
affect the principal conclusions of the paper.
Dr Anthony M. Imparato (New York, NY). I enjoyed
your paper and admire your interest in pursuing this subject.
Because it is the progression of a pathologic process that we
are trying to follow, I am surprised that you made no
attempt to identify the specific characteristics of the plaque,
which can be done noninvasively, at least to determine
whether the plaques are echogenic or not. And I think the
need for this is exemplified by the fact that your major para-
meter, which was predictive, was the degree of stenosis. We
know that the incidence of secondary changes beyond neo-
fibrous proliferation is the appearance of soft material in the
plaque. So, I would ask whether you had made any attempt
to determine that characteristic. And if not, I would urge
you to add it to your protocol. Thank you.
Dr Muluk. I thank you for your comments. I think you
make an important point, and it is something that we
would like to go back and examine. It is difficult to extract
those data because those data are available only in text for-
mat in our database and would require a fair amount of
work to extract, but we are indeed planning to do just that.
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